Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 2Phase 3 2Phase 2/3 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Osteoporosis 4Prostatic Neoplasms 3Breast Neoplasms 3Vitamin D Deficiency 2Polycystic Ovary Syndrome 2Neoplasms 2Cardiovascular Diseases 2Vitamin D3 1Neuroma 1Melanoma, Cutaneous Malignant 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Locally Advanced Breast Cancer and Large Operable Breast Cancer 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Insulin Resistance 1Fractures, Bone 1Colorectal Adenocarcinoma 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Pemetrexed 9Epoetin Alfa 9venetoclax 8Prednisone 8Fentanyl 8Drug Therapy 8Doxorubicin 8atezolizumab 7Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Cholecalciferol × Clear all
NCT01169259 2025-11-06

VITAL

Brigham and Women's Hospital

Phase 3 Active not recruiting
25,871 enrolled 38 charts

Cardiovascular Diseases, Neoplasms

NCT01646437 2021-09-16

TIPS-3

Population Health Research Institute

Phase 3 Completed
7,793 enrolled

Cardiovascular Diseases, Neoplasms, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡